Erlotinib: all 574 studies that test it
Page 5 of 6. Open to participants first (10), then studies with results posted, then the rest; newest registration first within each.
- Gemcitabine, Capecitabine, and Erlotinib in Treating Patients With Advanced Pancreatic CancerCompletedNCT00885066Phase 1
- Trial of PM02734 Administered in Combination With Erlotinib in Patients With Advanced Malignant Solid TumorsCompletedNCT00884845Phase 1
- Individualized Treatment Based on Epidermal Growth Factor Receptor Mutations and Level of BRCA1 Expression in Advanced AdenocarcinomaCompletedNCT00883480Not applicable
- Safety of MP470 in Combination With Standard-of-Care Chemotherapy Regimens to Treat Solid TumorsCompletedNCT00881166Phase 1
- GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by SurgeryActive, not recruitingNCT00878163Phase 1
- Erlotinib Versus Gemcitabine/Carboplatin in Chemo-naive Stage IIIB/IV Non-Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Exon 19 or 21 MutationCompletedNCT00874419Phase 3
- Trial to Evaluate the Efficacy and Safety of Tarceva and Capecitabine in Advanced Pancreatic Cancer PatientsCompletedNCT00873353Phase 2
- Study of Erlotinib With Docetaxel in Selected Non Small Cell Lung Cancer Patients in First Line TreatmentCompletedNCT00840125Phase 2
- 2nd Line Erlotinib Treatment With (Out) Chemotherapy of Advanced Non Small Cell Lung Cancer (NSCLC)CompletedNCT00835471Phase 2
- A Study to Assess the Efficacy of Erlotinib for Leptomeningeal Carcinomatosis in EGFR Mutation Positive Non-small Cell Lung CancerTerminatedNCT00830245Phase 2
- A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid TumorsTerminatedNCT00811993Phase 1
- Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to ChemotherapyStatus unknownNCT00801385Phase 2
- Dose Finding Study of AVE1642 in Patients With Advanced or Metastatic Liver CarcinomaTerminatedNCT00791544Phase 1/2
- Dual Inhibition of EGFR Signalling Using the Combination of Cetuximab and ErlotinibStatus unknownNCT00784667Phase 2
- Docetaxel Intermittent-Erlotinib (Tarceva®) In Metastatic Non Small Cell Lung Cancer (NSCLC)TerminatedNCT00783471Phase 2
- Comparison of Biomarker Modulation by Inhibition of EGFR and/or SRC FamilyCompletedNCT00779389Phase 1
- Safety Study of XL765 (SAR245409) in Combination With Erlotinib in Adults With Solid TumorsCompletedNCT00777699Phase 1
- Erlotinib and Temsirolimus for Solid TumorsCompletedNCT00770263Phase 1
- PK Trial of Sorafenib & Erlotinib in Patients With Refractory Solid TumorsCompletedNCT00759928Phase 1
- Study of ABT-869 in Combination With Tarceva in Subjects With Solid TumorsWithdrawnNCT00754104Phase 1
- Combination of Erlotinib and Bevacizumab as Second-line Treatment in Patients With Non-small Cell Lung CancerTerminatedNCT00749567Phase 2
- A Phase 1 Dose-escalation Study of OSI-906 and Erlotinib (Tarceva®)CompletedNCT00739453Phase 1
- Phase I Study of LBH589 & Erlotinib for Advanced Aerodigestive Tract CancersCompletedNCT00738751Phase 1
- Stereotactic Radiosurgery and Erlotinib in Treating Patients With Non-Small Cell Lung Cancer and Brain MetastasesWithdrawnNCT00738335Phase 1
- Phase I Imaging Study Evaluating Dalotuzumab (MK0646) in Combination With Erlotinib for Patients With Non-Small Cell Lung Cancer (MK-0646-008)CompletedNCT00729742Phase 1
- Phase II Study Of Neoadjuvant Chemotherapy In Borderline Resectable Pancreatic AdenocarcinomaWithdrawnNCT00728000Phase 2
- A Phase 1 Dose-Escalation Study in Advanced Solid Tumors, Lymphomas or Multiple MyelomaCompletedNCT00725634Phase 1
- Erlotinib and Sorafenib in Chemonaive Patients With Locally Advanced or Metastatic Non Small Cell Lung CancerStatus unknownNCT00722969Phase 2
- Early Prediction of Therapeutic Response to Targeted Therapy in Stage IIIB/IV or Recurrent Lung Cancer PatientsCompletedNCT00708448Phase 1
- Study of Polyphenon E in Addition to Erlotinib in Advanced Non Small Cell Lung CancerTerminatedNCT00707252Phase 1
- Study of Combination Therapy of Carboplatin -Gemcitabine Plus Bevacizumab Beyond Progression in Patients With Locally Advanced and/or Metastatic Non-small Cell Lung Cancer (NSCLC) Who Have Not Received Prior Systemic TherapyCompletedNCT00702975Phase 2
- Study of Oral Vinorelbine and Erlotinib in Non-Small Cell Lung CancerCompletedNCT00702182Phase 1
- Safety Study of XL147 (SAR245408) in Combination With Erlotinib in Adults With Solid TumorsCompletedNCT00692640Phase 1
- Concurrent Chemoradiotherapy Containing Paclitaxel&Cisplatin With/Without Tarceva in Locally Advanced Esophageal CancerStatus unknownNCT00686114Phase 3
- Erlotinib Versus Carboplatin/Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)Status unknownNCT00678964Phase 2
- Laboratory Test in Predicting Response to Erlotinib in Patients With Relapsed Metastatic or Unresectable Non-Small Cell Lung Cancer That Did Not Respond to Previous TreatmentCompletedNCT00673569Phase 2
- Efficacy of Erlotinib for Brain Metastasis of Non-Small Cell Lung CancerStatus unknownNCT00663689Phase 2
- Tarceva Italian Lung Optimization tRialStatus unknownNCT00637910Phase 3
- Gemcitabine With or Without Capecitabine and/or Radiation Therapy or Gemcitabine With or Without Erlotinib in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by SurgeryCompletedNCT00634725Phase 3
- Induction Chemotherapy Followed by CCRT According to EGFR Mutation Status in NSCLC IIIStatus unknownNCT00620269Phase 2
- A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid TumorsCompletedNCT00619424Phase 1
- Erlotinib as 1st Line Treatment in NSCLC Stage IIIB/IVCompletedNCT00615758Phase 2
- Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic CancerCompletedNCT00614653Phase 1
- Ph I Dasatinib + Erlotinib in Recurrent MGCompletedNCT00609999Phase 1
- Phase I Study of OSI-930 and Erlotinib in Cancer TumorsCompletedNCT00603356Phase 1
- Erlotinib and Surgery in Treating Patients With Head and Neck Cancer That Can Be Removed by SurgeryCompletedNCT00601913Early Phase 1
- Induction Erlotinib Therapy in Stage III A (N2) Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00600587Phase 2
- Chemotherapy and Avastin Followed by Maintenance Treatment With Avastin +/- TarcevaCompletedNCT00598156Phase 3
- Phase I Study of Indibulin in Combination With Erlotinib in Advanced Solid TumorsCompletedNCT00591383Phase 1
- Erlotinib and Sunitinib in NSCLCCompletedNCT00581789Phase 1
- Erlotinib and Everolimus in Treating Patients With Metastatic Breast CancerCompletedNCT00574366Phase 1
- The Role of Erlotinib an Epidermal Growth Factor Receptor (EGFR) Inhibitor in the Treatment of Myelodysplastic SyndromeWithdrawnNCT00570375Phase 2
- Erlotinib and Sequential Positron Emission Tomography (PET) in Advanced Non Small Cell Lung Cancer (NSCLC)Status unknownNCT00568841Phase 2
- Erlotinib in Treating Patients With Barrett EsophagusStatus unknownNCT00566800Phase 1
- Combination Study of Capecitabine and Erlotinib Concurrent With Radiotherapy for Non-Operable Advanced Pancreatic CancerCompletedNCT00565487Phase 1
- WBRT & Erlotinib in Advanced NSCLC and Brain MetastasesTerminatedNCT00554775Phase 2
- Bevacizumab, Erlotinib, and Capecitabine for Locally Advanced Rectal CancerCompletedNCT00543842Phase 1
- Bevacizumab in Multiple Phase I CombinationsCompletedNCT00543504Phase 1
- Safety Study of Radiotherapy and Concurrent Erlotinib (Tarceva®) for Brain Metastases From a Non-Small Cell Lung CancerCompletedNCT00536861Phase 1
- A Study of Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Patients With Advanced Pancreatic CancerSuspendedNCT00536770Phase 2
- Inoperable Non-Squamous NSCLC Stage III/IV: A Randomised Phase II Study With Bevacizumab Plus Erlotinib Or Gemcitabine/Cisplatin Plus BevacizumabCompletedNCT00536640Phase 2
- Clinical Trial of the Safety and Effectiveness of CHR-2797 With Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung CancerTerminatedNCT00522938Phase 1/2
- Study of Pegylated Alfa Interferon, Sunitinib and Tarceva in Patients With Metastatic RCCTerminatedNCT00522249Phase 1/2
- Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant GliomaCompletedNCT00509431Phase 1
- Phase II Trial of Erlotinib in Advanced Pancreatic CancerCompletedNCT00497224Phase 2
- Erlotinib Plus Chemotherapy for Treatment of Triple Negative Breast CancerStatus unknownNCT00491816Phase 2
- A Phase I Trial of Capecitabine in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic CancerCompletedNCT00480584Phase 1
- Phase II Trial of Tarceva in Patients With Non-Small Cell Lung CancerStatus unknownNCT00466284Phase 2
- Study of 3D Radiotherapy With or Without Erlotinib (Tarceva®) in Patients With Localized Non-Small Cell Lung CancerStatus unknownNCT00466089Phase 2
- Surgery for Early Lung Cancer With Preoperative Erlotinib (Tarceva): A Clinical Phase II Trial (SELECT)CompletedNCT00462995Phase 2
- Study of the Antitumor Activity of Capecitabine in Combination With Erlotinib in Patients With Metastatic Colorectal CancerTerminatedNCT00459901Phase 2
- Erlotinib as First-line Treatment of Advanced Non-small Cell Lung Cancer (NSCLC) for Patients Unfit for ChemotherapyTerminatedNCT00452075Phase 2
- Phase I Dasatinib/Erlotinib in Recurrent Non-small Cell Lung Cancer (NSCLC)CompletedNCT00444015Phase 1
- Trial of Pemetrexed Versus Erlotinib in Pretreated Patients With Non Small Cell Lung Cancer (NSCLC)CompletedNCT00440414Phase 3
- Erlotinib, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB-Stage IVA Cervical CancerWithdrawnNCT00428194Phase 1
- Safety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem GliomaCompletedNCT00418327Phase 1
- Erlotinib in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00416650Phase 2
- Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck CancerCompletedNCT00405405Phase 1
- Secondary Primary Tumor Prevention With EGFR, OSI-774, and Cyclooxygenase-2CompletedNCT00400374Phase 1
- Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerCompletedNCT00397384Phase 1
- Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation Therapy for Non-small Cell Lung Cancer (PEARL)CompletedNCT00391248Phase 2
- Pemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid TumorsCompletedNCT00387322Phase 1/2
- QOL-Stereotactic RadioSurgery, Temozolomide + Erlotinib-Rx of 1-3 Brain Metastases in NSCLCWithdrawnNCT00385398Phase 2
- Therapeutic Strategy in Advanced Bronchioloalveolar CarcinomaCompletedNCT00384826Phase 2
- A Study to Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic CancerCompletedNCT00369889Phase 2
- Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem GliomaStatus unknownNCT00360854Phase 1
- Bevacizumab and Erlotinib Followed by Cisplatin or Carboplatin and Gemcitabine in Treating Patients With Newly Diagnosed or Recurrent Stage IIIB or Stage IV NSCLCCompletedNCT00354549Phase 2
- TORCH: A Study of Tarceva or Chemotherapy for the Treatment of Advanced Non Small Cell Lung CancerCompletedNCT00349219Phase 3
- First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR GeneStatus unknownNCT00339586Phase 2
- A Study of the Safety and Efficacy of Tarceva in Patients With First Relapse of Grade IV Glioma (Glioblastoma Multiforme)CompletedNCT00337883Phase 2
- Trial Of Erlotinib With Or Without PF-3512676 In Advanced Non Small Cell Lung CancerCompletedNCT00321815Phase 2
- Vinflunine and Erlotinib or Pemetrexed in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT00320073Phase 1
- IFCT-GFPC 05.02 A Randomized Phase III Trial Assessing in Patients With Advanced Non-small Cell Lung CancerCompletedNCT00300586Phase 3
- A Two-Stage Phase 1 Dose Escalation Pharmacokinetic Study of Tarceva in Patients With Stage IIIB/IV Non-small Cell Lung Cancer Who Continue to Smoke After Failure of One or Two Prior Chemotherapy RegimensCompletedNCT00294736Phase 1
- Celecoxib and Erlotinib in Treating Patients With Liver CancerWithdrawnNCT00293436Phase 1/2
- A Study of Tarceva for Use in Patients With Relapsed or Refractory Metastatic Non-Small Cell Lung CancerTerminatedNCT00283634Phase 2
- Erlotinib in Treating Patients With Metastatic and/or Recurrent Head and Neck CancerCompletedNCT00281866Phase 2
- Volociximab and Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerStatus unknownNCT00278187Phase 2
- Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid TumorsCompletedNCT00276575Phase 1
- Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00275132Phase 3